人交界性上皮性卵巢肿瘤中的p53基因突变 - Suppr | 超能文献

p53 gene mutation in human borderline epithelial ovarian tumors.

作者信息

Wertheim I, Muto M G, Welch W R, Bell D A, Berkowitz R S, Mok S C

机构信息

Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

出版信息

J Natl Cancer Inst. 1994 Oct 19;86(20):1549-51. doi: 10.1093/jnci/86.20.1549.

DOI:10.1093/jnci/86.20.1549

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

p53 gene mutation in human borderline epithelial ovarian tumors.人交界性上皮性卵巢肿瘤中的p53基因突变

J Natl Cancer Inst. 1994 Oct 19;86(20):1549-51. doi: 10.1093/jnci/86.20.1549.

2

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.上皮性卵巢癌的克隆起源：通过杂合性缺失、p53 突变和 X 染色体失活进行分析。

J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793.

3

Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.与卵巢癌相邻的形态学上良性囊肿与孤立性囊腺瘤之间的基因差异。

J Natl Cancer Inst. 1995 Aug 2;87(15):1146-53. doi: 10.1093/jnci/87.15.1146.

4

p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.卵巢癌中的p53突变、17号染色体短臂等位基因缺失及DNA含量

J Pathol. 1996 Jun;179(2):177-82. doi: 10.1002/(SICI)1096-9896(199606)179:2<177::AID-PATH561>3.0.CO;2-2.

5

Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors.人交界性和浸润性上皮性卵巢肿瘤中9号染色体短臂及p16基因改变的详细缺失图谱分析

Oncogene. 1995 Oct 5;11(7):1249-54.

6

p53 expression in ovarian borderline tumors and stage I carcinomas.

Am J Clin Pathol. 1994 Nov;102(5):671-6. doi: 10.1093/ajcp/102.5.671.

7

p53 mutation is infrequent in clear cell carcinoma of the ovary.p53突变在卵巢透明细胞癌中并不常见。

Gynecol Oncol. 2001 Feb;80(2):189-93. doi: 10.1006/gyno.2000.6025.

8

p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma.p53基因状态与晚期卵巢癌对铂类/紫杉醇化疗的反应

J Clin Oncol. 2000 Dec 1;18(23):3936-45. doi: 10.1200/JCO.2000.18.23.3936.

9

p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.上皮性卵巢肿瘤中的p53和Ki-ras基因突变

Cancer Res. 1993 Jul 1;53(13):3103-8.

10

Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.p53基因在人类卵巢肿瘤17号染色体短臂等位基因缺失中的作用。

Anticancer Res. 1991 Nov-Dec;11(6):1975-82.

引用本文的文献

1

The Putative Role of Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review.改变和p53表达在卵巢交界性肿瘤中的假定作用——与临床病理特征及预后的相关性：一篇综述

J Cancer. 2017 Aug 22;8(14):2684-2691. doi: 10.7150/jca.19691. eCollection 2017.

2

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.散发性卵巢癌以及两种不同BRCA1始祖突变携带者中TP53突变；与诊断年龄和生存率的关系。

BMC Cancer. 2005 Oct 17;5:134. doi: 10.1186/1471-2407-5-134.

3

Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.人上皮性卵巢癌中Bcl-2和p53蛋白表达、细胞凋亡及p53突变

Am J Pathol. 2000 Feb;156(2):409-17. doi: 10.1016/S0002-9440(10)64744-X.

4

Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer.上皮性卵巢癌中6号染色体q27区域杂合性缺失及p53基因突变

Med Oncol. 1998 Jul;15(2):119-23. doi: 10.1007/BF02989590.